Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 8
Submit an article Journal homepage
15,891
Views
59
CrossRef citations to date
0
Altmetric
Review

Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia

Wanda SalzerU.S. Army, Medical Research and Materiel Command, Fort Detrick, MD, USA; Correspondence[email protected]
View further author information
,
Bruce BostromChildren’s of Minnesota, Minneapolis, MN, USA; View further author information
,
Yoav MessingerChildren’s of Minnesota, Minneapolis, MN, USA; ORCID Iconhttp://orcid.org/0000-0001-7990-1802View further author information
ORCID Icon,
Anthony J. PerissinottiUniversity of Michigan, College of Pharmacy, Ann Arbor, MI, USAView further author information
&
Bernard MariniUniversity of Michigan, College of Pharmacy, Ann Arbor, MI, USAView further author information
Pages 1797-1806 | Received 02 Jun 2017, Accepted 18 Sep 2017, Published online: 18 Oct 2017

Citations (59)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Amani Alqahtani, Diala Alhousari, Amir Ali, George Yaghmour, Etan Orgel, Emily Curran, Wendy Stock, Deepa Bhojwani & Houda Alachkar. (2023) Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding. Expert Opinion on Drug Metabolism & Toxicology 19:6, pages 357-366.
Read now
Melissa Sandley & Jonathan Angus. (2023) Asparaginase therapy in patients with acute lymphoblastic leukemia: expert opinion on use and toxicity management. Leukemia & Lymphoma 64:4, pages 776-787.
Read now
Krishna R Juluri, Chloe Siu & Ryan D Cassaday. (2022) Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy. Blood and Lymphatic Cancer: Targets and Therapy 12, pages 55-79.
Read now
Hesham Saeed, Eman Elsawy, Manal Shalaby, Manal Abdel-Fattah, Asmaa Hemida, Ahmad Eldoksh, Farid Shokry Ataya, Hesham Nematalla, Mohamed Elkewedi, Nikolaos N. Labrou & Nefertiti El-Nikhely. (2022) L-asparaginase from Dickeya chrysanthemi: expression, purification and cytotoxicity assessment. Preparative Biochemistry & Biotechnology 52:6, pages 668-680.
Read now
Ana Calheiros de Carvalho, Claudio Yoshio Ogawa$suffix/text()$suffix/text(), Luiza De Camillis Rodrigues, Lívia Soman de Medeiros & Thiago André Moura Veiga. (2021) Penicillium genus as a source for anti-leukemia compounds: an overview from 1984 to 2020. Leukemia & Lymphoma 62:9, pages 2079-2093.
Read now
Benjamin A. Derman, Mitchell Streck, Joseph Wynne, Trevor N. Christ, Emily Curran, Wendy Stock & Randall W. Knoebel. (2020) Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. Leukemia & Lymphoma 61:3, pages 614-622.
Read now
Bernard L. Marini, Julia Brown, Lydia Benitez, Emily Walling, Raymond J. Hutchinson, Rajen Mody, Rama Jasty Rao, Lynn Slagle, Lauren Bishop, Kristen Pettit, Dale L. Bixby, Patrick W. Burke & Anthony J. Perissinotti. (2019) A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage. Leukemia & Lymphoma 60:12, pages 2854-2868.
Read now
Meghan Pike, Ketan Kulkarni & Tamara MacDonald. (2019) Asparaginase activity monitoring experience from the Maritimes, Canada. Leukemia & Lymphoma 60:9, pages 2312-2315.
Read now

Articles from other publishers (51)

Sarah Menig, Andrew Dinh, Jonathan Angus, Sarah Tucker, Kasey J. Leger, Teresa Rushing & Etan Orgel. (2023) Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison. Pediatric Blood & Cancer 71:1.
Crossref
Ryan D. Cassaday. (2023) Asparaginase dosing for obese patients with acute lymphoblastic leukemia and factors that contribute to outcomes. Best Practice & Research Clinical Haematology 36:4, pages 101519.
Crossref
Taylor D. Coe-Eisenberg, Anthony J. Perissinotti, Bernard L. Marini, Kristen M. Pettit, Dale L. Bixby, Patrick W. Burke & Lydia Benitez. (2023) Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring. Annals of Hematology.
Crossref
Sammara Chaubard, Amira Marouf, David Lavergne, François Lemonnier, Julien Rossignol, Aline Clavert, Rémy Gressin, Guillaume Cartron, Agathe Waultier‐Rascalou, Jacques Vargaftig, Gilles Salles, Emmanuel Bachy, Hervé Ghesquières, Olivier Tournilhac, Adrien Chauchet, Steven Le Gouill, Gandhi Damaj, Luc‐Matthieu Fornecker, David Sibon, Lucie Obéric, Jean‐Marie Michot, Philippe Gaulard, Olivier Hermine, Lucile Couronné & Arnaud Jaccard. (2023) Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L‐asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK /T‐cell lymphoma: A French retrospective study . British Journal of Haematology 201:4, pages 673-681.
Crossref
Catherine E. Martin, Mira A. Kohorst, Asmaa Ferdjallah, Jessica L. Kalmes, Heather M. Johnson, Paul J. Galardy, Shakila P. Khan & Alexis K. Kuhn. (2023) Symptomatic hyperammonemia secondary to recombinant Erwinia asparaginase . Pediatric Blood & Cancer 70:5.
Crossref
Luis Peña Icart, Talita Stelling de Araújo, Marcius da Silva Almeida & Luís Maurício Trambaidi de Rocha e Lima. (2023) Modified Asparaginase for Treatment of Cancer Historical Appraisal and Future Perspectives. Current Applied Polymer Science 6:1, pages 14-25.
Crossref
Randal K Buddington, Karyl K Buddington & Scott C. Howard. (2022) Multiple Asparaginase Infusions Cause Increasingly Severe Acute Hyperammonemia. Medical Sciences 10:3, pages 43.
Crossref
Peiyun Liao, Ning Chang, Binyan Xu, Yingqi Qiu, Sheng Wang, Lijuan Zhou, Yanjie He, Xiaoling Xie & Yuhua Li. (2022) Amino acid metabolism: challenges and opportunities for the therapeutic treatment of leukemia and lymphoma. Immunology & Cell Biology 100:7, pages 507-528.
Crossref
Dan Douer, Nicola Gökbuget, Wendy Stock & Nicolas Boissel. (2022) Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia. Blood Reviews 53, pages 100908.
Crossref
Kyle J. Babcock, Amy Kinnunen, Tosha Egelund, John S. Ng & Michael J. Joyce. (2022) Efficacy of a Standardized Premedication and Therapeutic Drug Monitoring Protocol for Pegaspargase to Prevent Hypersensitivity Reactions. The Journal of Pediatric Pharmacology and Therapeutics 27:3, pages 232-236.
Crossref
Maaike Van Trimpont, Evelien Peeters, Yanti De Visser, Amanda M. Schalk, Veerle Mondelaers, Barbara De Moerloose, Arnon Lavie, Tim Lammens, Steven Goossens & Pieter Van Vlierberghe. (2022) Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy. Cancers 14:4, pages 902.
Crossref
Tapasvi Modi & David Gervais. (2021) Improved pharmacokinetic and pharmacodynamic profile of a novel PEGylated native Erwinia chrysanthemi L-Asparaginase. Investigational New Drugs 40:1, pages 21-29.
Crossref
Y. S. Korkina & T. T. Valiev. (2022) Asparaginase drugs: a new view of the mechanism of action, side effects and experience in BFM (Berlin–Frankfurt–Munster) protocols. Russian Journal of Pediatric Hematology and Oncology 8:4, pages 81-89.
Crossref
Iris Munhoz Costa, Débora Custódio Moura, Guilherme Meira Lima, Adalberto Pessoa, Camila Oresco dos Santos, Marcos A de Oliveira & Gisele Monteiro. (2021) Engineered asparaginase from Erwinia chrysanthemi enhances asparagine hydrolase activity and diminishes enzyme immunoreactivity ‐ a new promise to treat acute lymphoblastic leukemia . Journal of Chemical Technology & Biotechnology 97:1, pages 228-239.
Crossref
Montserrat Mesegué, Anna Alonso‐Saladrigues, Sara Pérez‐Jaume, Ariadna Comes‐Escoda, José Luís Dapena, Anna Faura, Nuria Conde, Albert Català, Anna Ruiz‐Llobet, Edgar Zapico‐Muñiz, Mireia Camós & Susana Rives. (2021) Lower incidence of clinical allergy with PEG‐asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG‐ASP in pediatric patients with acute lymphoblastic leukemia . Hematological Oncology 39:5, pages 687-696.
Crossref
Francisca Villanueva-Flores, Andrés Zárate-Romero, Alfredo G. Torres & Alejandro Huerta-Saquero. (2021) Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance. Pharmaceutics 13:11, pages 1965.
Crossref
Maristella Maggi, Greta Pessino, Isabella Guardamagna, Leonardo Lonati, Cristina Pulimeno & Claudia Scotti. (2021) A Targeted Catalytic Nanobody (T-CAN) with Asparaginolytic Activity. Cancers 13:22, pages 5637.
Crossref
Zuhal Eraslan, Grigorios Papatzikas, Jean-Baptiste Cazier, Farhat L. Khanim & Ulrich L. Günther. (2021) Targeting Asparagine and Serine Metabolism in Germinal Centre-Derived B Cells Non-Hodgkin Lymphomas (B-NHL). Cells 10:10, pages 2589.
Crossref
Mariana Bohns Michalowski & Daiane Keller Cecconello. (2021) Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia . Pediatric Blood & Cancer.
Crossref
Yuliya S. Korkina & Timur T. Valiev. (2021) L-asparaginase: New about Well-Known Drug. Pediatric pharmacology 18:3, pages 227-232.
Crossref
Mariana Bohns Michalowski, Daiane Keller Cecconello, Mecneide Mendes Lins, Maria do Perpétuo Socorro Sampaio Carvalho, Klerize Anecely de Souza Silva, Lilian Cristofani, Thais Alcantra Bonilha, Bianca Faustini Baglioli, Mara Albonei Dudeque Pianovski, Ana Paula Kuczynski, Pablo Santiago, Ciliana Rechenmacher, Ana Paula Alegretti, Karla Rodrigues, Mariana Rodrigues de Magalhães & Liane Esteves Daudt. (2021) Influence of different asparaginase formulations in the prognosis of children with acute lymphocytic leukaemia in Brazil: a multicentre, retrospective controlled study. British Journal of Haematology 194:1, pages 168-173.
Crossref
Lude Wang, Xiaoya Zhao, Jianfei Fu, Wenxia Xu & Jianlie Yuan. (2021) The Role of Tumour Metabolism in Cisplatin Resistance. Frontiers in Molecular Biosciences 8.
Crossref
Wing H Tong. (2021) Comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions. Journal of Oncology Pharmacy Practice 27:4, pages 1054-1056.
Crossref
David O. Riley, Jenna M. Schlefman, Hans Christoph Vitzthum Von Eckstaedt V, Amy L. Morris, Michael K. Keng & Firas El Chaer. (2021) Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit. Current Hematologic Malignancy Reports 16:3, pages 314-324.
Crossref
Hesham Saeed, Asmaa Hemida, Manal Abdel-Fattah, Ahmad Eldoksh, Manal Shalaby, Hisham Nematalla, Nefertiti El-Nikhely & Mohamed Elkewedi. (2021) Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines. Protein Expression and Purification 181, pages 105820.
Crossref
Lan Wang, Wenjing Qin, Ding Chen, Nanxiang Wang, Congcong Zhang, Zhijie Fang, Bin Fang, Wei Du, Naidi Yang, Qiong Wu, Bo Peng & Lin Li. (2021) Design, synthesis and application of fluorogenic probe for detecting l-asparaginase in serum samples. Results in Chemistry 3, pages 100103.
Crossref
Scott Raskin & Anne L. Angiolillo. 2021. Biochemical and Molecular Basis of Pediatric Disease. Biochemical and Molecular Basis of Pediatric Disease 635 690 .
Daiane Keller Cecconello, Ciliana Rechenmacher, Isabel Werlang, Priscila Pini Zenatti, Jose Andres Yunes, Ana Paula Alegretti, Claudia Lanvers-Kaminsky, Liane Esteves Daudt & Mariana Bohns Michalowski. (2020) Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center. Scientific Reports 10:1.
Crossref
Thomas C. Minshull, Amanda Wood, David Roberts, Christine Hallam, Joshua Lewis, Adetola Orekoya & David Gervais. (2020) Determination of extent of PEGylation using denaturing capillary isoelectric focussing. Analytical Biochemistry 611, pages 113953.
Crossref
Zheng Zhou, Bao Sun, Anzheng Nie, Dongsheng Yu & Meng Bian. (2020) Roles of Aminoacyl-tRNA Synthetases in Cancer. Frontiers in Cell and Developmental Biology 8.
Crossref
Iván González-Torres, Ernesto Perez-Rueda, Zahaed Evangelista-Martínez, Andrés Zárate-Romero, Angélica Moreno-Enríquez & Alejandro Huerta-Saquero. (2020) Identification of L-asparaginases from Streptomyces strains with competitive activity and immunogenic profiles: a bioinformatic approach . PeerJ 8, pages e10276.
Crossref
Manjunath Nookala Krishnamurthy, Gaurav Narula, Khushboo Gandhi, Ankita Awase, Ruta Pandit, Sunil Raut, Ritu Singh, Vikram Gota & Shripad Dinanath Banavali. (2020) Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia. JCO Global Oncology:6, pages 1009-1016.
Crossref
Debora SonciniPaola Minetto, Claudia Martinuzzi, Pamela BecheriniValeria FenuFabio Guolo, Katia TodoertiGiovanni Calice, Paola Contini, Maurizio MiglinoGiulia RivoliSara AquinoAlida Dominietto, Antonia CagnettaMario PassalacquaSantina BruzzoneAlessio Nencioni, Massimo Zucchetti, Tommaso Ceruti, Antonino Neri, Roberto M. LemoliMichele Cea. (2020) Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death. Blood Advances 4:18, pages 4312-4326.
Crossref
Veerle Mondelaers, Alina Ferster, Anne Uyttebroeck, Bénédicte Brichard, Jutte Werff ten Bosch, Koenraad Norga, Nadine Francotte, Caroline Piette, Katrien Vandemeulebroecke, Charlotte Verbeke, Susanne Schmidt, Yves Benoit, Tim Lammens & Barbara De Moerloose. (2020) Prospective, real‐time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non‐Hodgkin lymphoma in Belgium . British Journal of Haematology 190:1, pages 105-114.
Crossref
Daiane Keller Cecconello, Mariana Rodrigues de Magalhães, Isabel Cristina Ribas Werlang, Maria Lucia de Martino Lee, Mariana Bohns Michalowski & Liane Esteves Daudt. (2020) Asparaginase: an old drug with new questions. Hematology, Transfusion and Cell Therapy 42:3, pages 275-282.
Crossref
John C. Panetta, Yiwei Liu, Hope D. Swanson, Seth E. Karol, Ching‐Hon Pui, Hiroto Inaba, Sima Jeha & Mary V. Relling. (2020) Higher plasma asparaginase activity after intramuscular than intravenous Erwinia asparaginase. Pediatric Blood & Cancer 67:7.
Crossref
Subhash Chand, Richi V. Mahajan, Jai Prakash Prasad, Debendra K. Sahoo, Kanti Nandan Mihooliya, Mahesh S. Dhar & Girish Sharma. (2020) A comprehensive review on microbial l ‐asparaginase: Bioprocessing, characterization, and industrial applications . Biotechnology and Applied Biochemistry 67:4, pages 619-647.
Crossref
Gudrun WürthweinClaudia Lanvers-KaminskyJoachim GerssAnja MörickeMartin ZimmermannJan StaryPetr SmisekAndishe AttarbaschiChrista NathMassimo Zucchetti, Carmelo RizzariMartin SchrappeJoachim Boos. (2020) Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study. Therapeutic Drug Monitoring 42:3, pages 435-444.
Crossref
Komail Nadeem, David Colantonio, Ida Kircanski, Ahmed Naqvi, Johann Hitzler, James A. Whitlock & L. Lee Dupuis. (2019) Clinical decisions following implementation of asparaginase activity monitoring in pediatric patients with acute lymphoblastic leukemia: Experience from a single‐center study. Pediatric Blood & Cancer 67:2.
Crossref
Martina Chiu, Giuseppe Taurino, Massimiliano G. Bianchi, Michael S. Kilberg & Ovidio Bussolati. (2020) Asparagine Synthetase in Cancer: Beyond Acute Lymphoblastic Leukemia. Frontiers in Oncology 9.
Crossref
Najeebah A Bade, Crystal Lu, Ciera L Patzke, Maria R Baer, Vu H Duong, Jennie Y Law, Seung T Lee, Edward A Sausville, Ann B Zimrin, Alison P Duffy, Justin Lawson & Ashkan Emadi. (2019) Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management. Journal of Oncology Pharmacy Practice 26:1, pages 74-92.
Crossref
Kimberly M Lau, Ila M Saunders & Aaron Goodman. (2019) Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia. Journal of Oncology Pharmacy Practice 26:1, pages 193-199.
Crossref
Patrick W. Burke, Dieter Hoelzer, Jae H. Park, Kjeld Schmiegelow & Dan Douer. (2020) Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion. ESMO Open 5:5, pages e000858.
Crossref
Georg Hempel. 2020. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics 291 319 .
Keith J. August, Sana Farooki, Joy M. Fulbright, Amanda August, Jay M. Portnoy, Lauren Pommert, Michael J. Burke & Erin M. Guest. (2019) Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma. Pediatric Blood & Cancer 67:1.
Crossref
Stacy L. Cooper, David J. Young, Caitlin J. Bowen, Nicole M. Arwood, Sarah G. Poggi & Patrick A. Brown. (2019) Universal premedication and therapeutic drug monitoring for asparaginase‐based therapy prevents infusion‐associated acute adverse events and drug substitutions. Pediatric Blood & Cancer 66:8.
Crossref
Michael Losasso, Bruce Bostrom & Yoav Messinger. (2020) Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication. F1000Research 8, pages 1007.
Crossref
Michael Losasso, Bruce Bostrom & Yoav Messinger. (2019) Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication. F1000Research 8, pages 1007.
Crossref
Luiza Steffens, Mabilly Cox Holanda de Barros Dias, Ana Moira Morás, Dinara Jaqueline Moura & Michael Nugent. 2019. Natural Polysaccharides in Drug Delivery and Biomedical Applications. Natural Polysaccharides in Drug Delivery and Biomedical Applications 441 470 .
Georg Hempel. 2020. Pediatric Pharmacotherapy. Pediatric Pharmacotherapy 415 440 .
Maria Micaela Viña Romero, Sara García Gil, Gloria Julia Nazco Casariego, Javier Merino Alonso & Fernando Gutiérrez Nicolás. (2018) Actividad de Erwinia -asparraginasa tras reacción anafiláctica a Peg-asparraginasa. Anales de Pediatría.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.